Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2301studies shown
Showing 697-708 of 2,301
Drug study icon
Active Not RecruitingNCT05774665

Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression

This observational study is following people with Treatment Resistant Depression, Inflammation, or Overweight to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Depression
Drug study icon
CompletedNCT05220410

The Safety and Efficacy of Psilocybin in people with Treatment-resistant Depression and Chronic Suicide prevention

This study exists to better understand the safety of psilocybin treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to psilocybin treatment in practice and what may need to be adjusted.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, SuicidalityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Sheppard Pratt Health System
Condition
Depression, Suicidality
Drug study icon
TerminatedNCT04249596

Tianeptine for Treatment Resistant Depression

This study exists to see whether acceptance and commitment therapy, a talking treatment, can make care clearer and more responsive. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can give earlier or clearer feedback during care.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 21 Years to 60 Years
Countries
United States
Sponsor
Jonathan A. Javitch, MD, PhD
Condition
Depression
Drug study icon
CompletedNCT03265808

Allogeneic Human Mesenchymal Stem Cell Infusion vs Placebo in Addiction and Major Depression.

This study exists to better understand the safety of this type of care and how manageable it feels in practice. Researchers are trying to understand whether this type of care can work better when mental health difficulties overlap with substance use.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, AddictionDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
Ihsan M Salloum, MD, MPH
Condition
Depression, Addiction
Drug study icon
CompletedNCT02185131

Study of Mirtazapine for Co-occurring AD/MDD.

This study is completed in the United States. It focuses on Depression.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, AddictionDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
University of Pittsburgh
Condition
Depression, Addiction
Device study icon
TerminatedNCT02709161

Effects of Amygdala Neurofeedback on Depressive Symptoms

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 55 Years
Countries
United States
Sponsor
Kymberly Young
Condition
Depression
Drug study icon
CompletedNCT06419608

BHV-7000 Monotherapy for depression

This study is completed in the United States. It is testing BHV-7000 Monotherapy for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
Biohaven Therapeutics Ltd.
Condition
Depression
Behavioral study icon
CompletedNCT02607514

Hyperthermic Yoga for Depressive Symptoms

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 60 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.